Brief: Oasis: Initiates Shareholder Derivative Lawsuit Against Kobayashi Pharmaceutical Directors
Jan 28 (Reuters) - Kobayashi Pharmaceutical Co Ltd
4967.T :
* OASIS: INITIATES SHAREHOLDER DERIVATIVE LAWSUIT AGAINST
KOBAYASHI PHARMACEUTICAL DIRECTORS
* OASIS: ESTIMATES DAMAGES INCURRED BY KOBAYASHI PHARMA DUE
TO
DIRECTORS’ BREACH OF DUTIES RELATED TO CORPORATE GOVERNANCE
TOTAL ABOUT 11 BILLION YEN
Source text: https://www.businesswire.com/news/home/20250127757038/en/Oasis-Initiates-Shareholder-Derivative-Lawsuit-Against-Kobayashi-Pharmaceutical-Directors-Securities-Code-4967-JT
Further company coverage: 4967.T
(Reporting by Kantaro Komiya)
((Kantaro.Komiya@thomsonreuters.com;))
Recent news on Kobayashi Pharmaceutical
See all newsNotice Regarding Certain Media Reports
Brief: Japan's Kobayashi Pharmaceutical Considering Going Private Under Japan-UK Investment Fund Consortium, Bloomberg News Says
Brief: Oasis Management Raises Stake In Kobayashi Pharmaceutical To 14.41% From 13.37%, Filing Shows
Table: Kobayashi Pharmaceutical - 6-MTH group results
Brief: Oasis Management Company Is Making Shareholder Proposal To Kobayashi Pharmaceutical Co, Filing Shows